Showing results (251-260 of 1,811) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Transplantation and Cellular Therapy|May 9, 2021
Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 DeficiencyMark Parta, Kristen Cole, Daniele Avila, et al.
Transplantation and Cellular Therapy|April 29, 2021
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide EraAndrew Johnsrud, Abdullah Ladha, Lori Muffly, et al.
Transplantation and Cellular Therapy|April 28, 2021
Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive TherapyWolfgang Roll, Georg Evers, Rebecca Strotmann, et al.
Transplantation and Cellular Therapy|May 23, 2021
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid LeukemiaFevzi F Yalniz, Rima M Saliba, Uri Greenbaum, et al.
Transplantation and Cellular Therapy|July 18, 2025
Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed MyelomaThomas C Wiemers, Maximilian Ferle, Jonas Ader, et al.
Transplantation and Cellular Therapy|July 18, 2025
A 10-Year Follow-up Study of Children With Thalassemia Major Post-transplantation Using Treosulfan, Thiotepa, and Fludarabine-Based Conditioning Regimen and Its Impact on Growth and PubertyKavitha Ganesan, Vijayashree Muthukumar, Anupama Nair, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal ImpairmentTina Nguyen, Tanya Markary, Ni-Chun Tsai, et al.
Transplantation and Cellular Therapy|July 5, 2025
REMOVED: Post-Transplantation Cyclophosphamide Protects the Thymus from Alloreactive T-Cell Damage after T-Cell-Replete MHC-Haploidentical Hematopoietic Cell Transplantation but Does Not Rescue Normal Medullary Thymic Epithelial Cell Differentiation or Intrathymic Clonal DeletionAlessandra De Paula Pohl, Marie Pouzolles, Tsion Mekonmen, et al.
Transplantation and Cellular Therapy|July 3, 2025
Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCTRahul Banerjee, Hermioni L Amonoo, Anna Barata, et al.
Pageof 182